FIGS, Inc. logo

FIGS, Inc.

FIGS

NYSEConsumer CyclicalApparel - Manufacturers

Latest quote

$14.68

+$0.27 · +1.87%

Aug 21, 3:55 PM ET

FIGS company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

33

Expensive

Momentum

24

Weakening

Sentiment

73

Bullish

Risk resilience

38

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

FIGS, Inc. functions as a direct-to-consumer enterprise specializing in healthcare apparel and lifestyle merchandise across the United States. The company innovates and distributes a comprehensive selection of medical uniforms, complemented by a diverse array of non-scrub items. These offerings span functional pieces like lab coats, under-scrubs, compression socks, footwear, and masks, extending to activewear, loungewear, and outerwear such as performance leggings, sports bras, various tops (including super-soft pima cotton options), vests, and jackets. Customers can access and purchase FIGS' products directly through its integrated digital platform, which encompasses both its official website and mobile application. Founded in 2013, FIGS, Inc. is headquartered in Santa Monica, California.

Industry
Apparel - Manufacturers
Sector
Consumer Cyclical
Headquarters
US
CEO
Catherine Eva Spear
Listed since
May 27, 2021
Employees
359

Market position

Volume
1.94M
0.59× average
Average volume
3.29M
Average daily volume
Market cap
2.45B USD
Beta
1.02
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.83B USD
P/E (TTM)
39.55×
P/B (TTM)
5.52×
P/S (TTM)
3.45×
EV / EBITDA
32.63×
Earnings yield
1.84%
Free cash flow yield
2.85%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
68.43%
Operating margin
9.60%
Net margin
8.72%
Return on equity
7.83%
Return on assets
5.91%
Return on invested capital
5.56%

Financial health

Debt / equity
0.13×
Current ratio
4.94×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends79%50%20%-10%Gross margin, FY2021: 71.79%Gross margin, FY2022: 70.07%Gross margin, FY2023: 69.09%Gross margin, FY2024: 67.61%Gross margin, FY2025: 66.53%Operating margin, FY2021: 2.62%Operating margin, FY2022: 7.45%Operating margin, FY2023: 6.24%Operating margin, FY2024: 0.41%Operating margin, FY2025: 6.04%Net margin, FY2021: -2.28%Net margin, FY2022: 4.19%Net margin, FY2023: 4.15%Net margin, FY2024: 0.49%Net margin, FY2025: 5.43%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 71.79%. Gross margin FY2022 70.07%. Gross margin FY2023 69.09%. Gross margin FY2024 67.61%. Gross margin FY2025 66.53%. Operating margin FY2021 2.62%. Operating margin FY2022 7.45%. Operating margin FY2023 6.24%. Operating margin FY2024 0.41%. Operating margin FY2025 6.04%. Net margin FY2021 -2.28%. Net margin FY2022 4.19%. Net margin FY2023 4.15%. Net margin FY2024 0.49%. Net margin FY2025 5.43%.

Income trends

Revenue

631.1M USD+13.60%

Operating income

38.15M USD+1584.19%

Net income

34.25M USD+1159.19%
Income trends across reported periods695.16M USD438.9M USD182.64M USD−73.62M USDRevenue, FY2021: 419.59M USDRevenue, FY2022: 505.84M USDRevenue, FY2023: 545.65M USDRevenue, FY2024: 555.56M USDRevenue, FY2025: 631.1M USDOperating income, FY2021: 10.98M USDOperating income, FY2022: 37.67M USDOperating income, FY2023: 34.05M USDOperating income, FY2024: 2.27M USDOperating income, FY2025: 38.15M USDNet income, FY2021: −9.56M USDNet income, FY2022: 21.19M USDNet income, FY2023: 22.64M USDNet income, FY2024: 2.72M USDNet income, FY2025: 34.25M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 419.59M USD. Revenue FY2022 505.84M USD. Revenue FY2023 545.65M USD. Revenue FY2024 555.56M USD. Revenue FY2025 631.1M USD. Operating income FY2021 10.98M USD. Operating income FY2022 37.67M USD. Operating income FY2023 34.05M USD. Operating income FY2024 2.27M USD. Operating income FY2025 38.15M USD. Net income FY2021 −9.56M USD. Net income FY2022 21.19M USD. Net income FY2023 22.64M USD. Net income FY2024 2.72M USD. Net income FY2025 34.25M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue631.1M USD555.56M USD545.65M USD505.84M USD419.59M USD
Cost of goods sold211.26M USD179.94M USD168.68M USD151.38M USD118.37M USD
Gross profit419.84M USD375.62M USD376.96M USD354.46M USD301.22M USD
Selling, general, and administrative288.59M USD373.36M USD342.92M USD316.79M USD290.24M USD
Operating expenses381.69M USD373.36M USD342.92M USD316.79M USD290.24M USD
Interest income8.75M USD11.24M USD6.78M USD1.71M USD
Interest expense239K USD
Depreciation and amortization9.04M USD6.69M USD2.94M USD1.92M USD1.42M USD
Operating income38.15M USD2.27M USD34.05M USD37.67M USD10.98M USD
Net income34.25M USD2.72M USD22.64M USD21.19M USD−9.56M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
82%
9 beats, 1 miss, 1 met estimate
Average EPS surprise
+152.52%
11 comparable reports
Latest EPS result
0.11
Estimate 0.07 · Beat by 63.57%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.150.080.02-0.05Q1 '25MetQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 0.01, estimate 0.01, surprise 0.00%, Met estimate. Q2 2025, reported May 8, 2025: actual -0.001, estimate -0.01, surprise +93.70%, Beat. Q3 2025, reported Aug 7, 2025: actual 0.04, estimate 0.02, surprise +100.00%, Beat. Q4 2025, reported Nov 6, 2025: actual 0.05, estimate 0.02, surprise +150.00%, Beat. Q1 2026, reported Feb 26, 2026: actual 0.1, estimate 0.02, surprise +400.00%, Beat. Q2 2026, reported May 7, 2026: actual 0.03, estimate 0.01, surprise +200.00%, Beat. Q3 2026, reported Aug 6, 2026: actual 0.11, estimate 0.067, surprise +63.57%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 0.06, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates209.97M177.09M144.21M111.33MQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 151.83M USD, estimate 119.4M USD, surprise +27.16%, Beat. Q2 2025, reported May 8, 2025: actual 124.9M USD, estimate 119.4M USD, surprise +4.61%, Beat. Q3 2025, reported Aug 7, 2025: actual 152.64M USD, estimate 143.8M USD, surprise +6.15%, Beat. Q4 2025, reported Nov 6, 2025: actual 151.66M USD, estimate 165.08M USD, surprise -8.13%, Miss. Q1 2026, reported Feb 26, 2026: actual 201.9M USD, estimate 165.32M USD, surprise +22.13%, Beat. Q2 2026, reported May 7, 2026: actual 159.9M USD, estimate 153.15M USD, surprise +4.41%, Beat. Q3 2026, reported Aug 6, 2026: actual 196.62M USD, estimate 186.17M USD, surprise +5.61%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 182.9M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$18.00

22.62% upside
Past 12 months12-month forecastHigh $20.00Average $18.00Low $16.00

Rating distribution

15 ratings
Strong buy00%
Buy960%
Hold427%
Sell213%
Strong sell00%

Recent analyst actions

9 institutions
Roth MKMmaintainBuy

FIGS peers

ETFs holding FIGS

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research FIGS

research.disclaimer